Desmond A Schatz, MD - Research

Research at a glance

Top areas of exploration

Diabetes Mellitus, Type 1 , 253 publications
Autoantibodies , 92 publications
Insulin , 68 publications
Islets of Langerhans , 49 publications

Research activity

381 publications

23,284 citations

Why is this important?

Active clinical trials

ITN095AI DESIGNATE

This is a multicenter, Phase Ib, open-label, siplizumab dose-finding study in individuals aged 8-45 years with a Type 1 diabetes mellitus (T1DM) diagnosis. within 18 months of V0. Participants will be randomized 1:1:1:1 to one of four possible鈥�

Investigator: Desmond A Schatz
Status: Accepting Candidates
Ages: 8 Years - 45 Years
Sexes: All

My publications

381 publications

2023

The ISPAD Clinical Practice Consensus Guidelines 2022: how far we have come and the distance still to go.

The lancet. Diabetes & endocrinology

鈥�

2023

The role of health system penetration rate in estimating the prevalence of type 1 diabetes in children and adolescents using electronic health records.

Journal of the American Medical Informatics Association : JAMIA

鈥�

2023

Time for changes in type 1 diabetes intervention trial designs.

The lancet. Diabetes & endocrinology

鈥�

2023

Type 1 Diabetes: A Disorder of the Exocrine and Endocrine Pancreas.

Journal of cellular immunology

鈥�

2022

A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670G.

Diabetes technology & therapeutics

鈥�

BOB体育